Yooma Wellness Inc

PINK:LVVEF USA Drug Manufacturers - Specialty & Generic
Market Cap
$110.95K
Market Cap Rank
#40796 Global
#13231 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$21.71
About

Yooma Wellness Inc. engages in the manufacturing, marketing, distribution, and sale of wellness products in Canada, Europe, Japan, China, and the United States. Its wellness products include hemp seed oil and hemp-derived cannabinoid (CBD) ingredients. The company sells its products through various platforms, such as ecommerce, mass-market retail, and independent retail partners. Yooma Wellness I… Read more

Yooma Wellness Inc (LVVEF) - Net Assets

Latest net assets as of September 2022: $11.95 Million USD

Based on the latest financial reports, Yooma Wellness Inc (LVVEF) has net assets worth $11.95 Million USD as of September 2022.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($30.68 Million) and total liabilities ($18.72 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $11.95 Million
% of Total Assets 38.97%
Annual Growth Rate 145.02%
5-Year Change 13509.04%
10-Year Change N/A
Growth Volatility 13229.6

Yooma Wellness Inc - Net Assets Trend (2016–2021)

This chart illustrates how Yooma Wellness Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Yooma Wellness Inc (2016–2021)

The table below shows the annual net assets of Yooma Wellness Inc from 2016 to 2021.

Year Net Assets Change
2021-12-31 $15.30 Million +31.89%
2020-12-31 $11.60 Million -16.14%
2019-12-31 $13.83 Million -62.89%
2018-12-31 $37.26 Million +33053.33%
2017-12-31 $112.40K -35.15%
2016-12-31 $173.34K --

Equity Component Analysis

This analysis shows how different components contribute to Yooma Wellness Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3465325400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2021)

Component Amount Percentage
Common Stock $50.18 Million 328.05%
Other Comprehensive Income $-235.54K -1.54%
Other Components $792.71K 5.18%
Total Equity $15.30 Million 100.00%

Yooma Wellness Inc Competitors by Market Cap

The table below lists competitors of Yooma Wellness Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Yooma Wellness Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2020 to 2021, total equity changed from 3,193,958 to 15,296,693, a change of 12,102,735 (378.9%).
  • Net loss of 33,117,145 reduced equity.
  • New share issuances of 9,831,467 increased equity.
  • Other comprehensive income decreased equity by 1,855,762.
  • Other factors increased equity by 37,244,175.

Equity Change Factors (2020 to 2021)

Factor Impact Contribution
Net Income $-33.12 Million -216.5%
Share Issuances $9.83 Million +64.27%
Other Comprehensive Income $-1.86 Million -12.13%
Other Changes $37.24 Million +243.48%
Total Change $- 378.93%

Book Value vs Market Value Analysis

This analysis compares Yooma Wellness Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.01x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 $0.00 $0.00 x
2017-12-31 $3.11 $0.00 x
2018-12-31 $5.47 $0.00 x
2019-12-31 $2.00 $0.00 x
2020-12-31 $0.46 $0.00 x
2021-12-31 $0.20 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Yooma Wellness Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -216.50%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -325.17%
  • • Asset Turnover: 0.28x
  • • Equity Multiplier: 2.39x
  • Recent ROE (-216.50%) is below the historical average (3179.95%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -25.20% 0.00% 0.00x 1.04x $-61.02K
2017 19640.69% 0.00% 0.00x 1.17x $22.07 Million
2018 -72.21% -4032.13% 0.02x 1.03x $-30.67 Million
2019 -96.20% -8752.01% 0.01x 1.01x $-14.69 Million
2020 -150.89% -10850.35% 0.00x 3.72x $-5.14 Million
2021 -216.50% -325.17% 0.28x 2.39x $-34.65 Million

Industry Comparison

This section compares Yooma Wellness Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Yooma Wellness Inc (LVVEF) $11.95 Million -25.20% 1.57x $108.72K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million